During the past decade, Kumamoto Chuo Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Kumamoto Chuo Hospital" are "Coronary Artery Disease" (2 trials), "Angina Pectoris" (1 trials), "Coronary Artery Occlusion" (1 trials), "Ischemic Heart Disease" (1 trials) and "Myocardial Ischemia" (1 trials). Many other conditions were trialed in "Kumamoto Chuo Hospital" in a lesser frequency.

Most popular intervention types in "Kumamoto Chuo Hospital" are "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Cypher stent" (1 trials), "TAXUS stent" (1 trials) and "XIENCE PRIME SV Everolimus Eluting Coronary Stent" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kumamoto Chuo Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Kumamoto Chuo Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Kumamoto Chuo Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kumamoto Chuo Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".